Clinical Trial Update: Evaluation of GlaxoSmithKline Biologicals' Boostrix® Vaccine in Comparison With Decavac™ Vaccine. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Boostrix vaccine versus Decavac for tetanus and acellular pertussis; completed with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acellular Pertussis
• Diphtheria
• Diphtheria-tetanus-acellular Pertussis Vaccines
• Tetanus

Drugs mentioned

• Boostrix (Diphtheria, Tetanus, and Acellular Pertussis Vaccine)
• Decavac (diphtheria-tetanus-acellular pertussis vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Tetanus, Acellular Pertussis | Phase 3 | Status: COMPLETED | Results posted: 2010-08-05